Picking the right agency to review device/drug combinations in the EU
This article was originally published in SRA
Manufacturers of device/drug combinations in the EU can choose which competent authority reviews the drug element of their product. The drugs world, however, can be a mystery for those with a devices background. So where do these companies start? In theory, the EU is their oyster. In practice, though, only a few authorities seem to offer the service required. Amanda Maxwell reports.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.
How to get non-CE-marked medical devices onto the UK market at speed